![]() | Patrick S MooreShow email addressDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA | Cancer Virology Program, Hillman Cancer Center, ... |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
Patrick S Moore:Expert Impact
Concepts for whichPatrick S Moorehas direct influence:Merkel cell,Merkel cell polyomavirus,Cell polyomavirus,Merkel cell carcinoma,Kaposi sarcoma,Cell lines,Human herpesvirus,Kaposis sarcoma.
Patrick S Moore:KOL impact
Concepts related to the work of other authors for whichfor which Patrick S Moore has influence:Human herpesvirus,Kaposi sarcoma,Merkel cell carcinoma,Pancreatic cancer,Gene expression,Primary effusion lymphoma,Endothelial cells.
KOL Resume for Patrick S Moore
Year | |
---|---|
2022 | Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA |
2021 | Cancer Virology Program, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA |
2020 | Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hillman Cancer Center, Cancer Virology Program, University of Pittsburgh, Pittsburgh, Pennsylvania, USA |
2019 | Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania 15213 |
2018 | Cancer Virology Program, University of Pittsburgh, Pittsburgh, PA, USA |
2017 | Cancer Virology Program, University of Pittsburgh, Pittsburgh, PA 15213 |
2016 | Cancer Virology Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA. |
2015 | Cancer Virology Program, University of Pittsburgh Cancer Institute, Suite 1.8, 5117 Centre Avenue, Pittsburgh, PA 15213, United States |
2014 | Cancer Virology Program, Cancer Institute, University of Pittsburgh, Pennsylvania |
2013 | Cancer Virology Program, University of Pittsburgh, Pittsburgh, PA 15213, USA |
2012 | School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, Cancer Virology Program, Hillman Cancer Center, 5117 Centre Avenue, Pittsburgh, PA 15213, USA and, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany Cancer Virology Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA |
2011 | From the, Cancer Virology Program, UNIVERSITY OF PITTSBURGH CANCER INSTITUTE Author affiliations: University of Pittsburgh, Pittsburgh, Pennsylvania, USA (Y.L. Tolstov, A. Knauer, T.W. Kensler, L.A. Kingsley, P.S. Moore, Y. Chang); Johns Hopkins University, Baltimore, Maryland, USA (T.W. Kensler) Qidong Liver Cancer Institute, Jiangsu, People’s Republic of China (J.G. Chen); |
2010 | Molecular Virology Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, PA Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, PA Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, PA Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY Jane Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California School of Medicine, Los Angeles Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, PA Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, PA |
2009 | Molecular Virology Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA |
2008 | Molecular Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, 5117 Centre Avenue, Suite 1.8, Pittsburgh, PA 15213; and ‡Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 303 East Chicago Avenue, Chicago, IL 60611 Department of Pathology, University of Verona, Verona, Italy University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA |
2007 | Molecular Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15213 |
2006 | Molecular Virology Program, University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, Pennsylvania From the Dipartimento di Sanità Pubblica, Sezione di Medicina del Lavoro, Università di Cagliari, Cagliari (P.C., M.G.T., A.I., M.M., G.S., C.F.); Dipartimento di Patologia, Università di Verona (P.S.M., S.M., A.S.); Dipartimento di Citomorfologia, Università di Cagliari, Monserrato, Cagliari (M.G.E., S.C., M.Z.); and Divisione di Ematologia, Ospedale San Francesco, ASL 3, Nuoro, Italy (M.M., G.P.) Department of Pathology, Section of Anatomic Pathology, University of Verona, Verona, Italy |
2005 | Deparment of Pathology, Section of Anatomic Pathology, Università di Verona, Verona, Italy University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA |
2004 | Dipartimento di Patologia, Università degli Studi di Verona, Strada Le Grazie, 8, 37134 Verona, Italy |
2003 | Molecular Virology Program, Hillman Cancer Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15213-1863; email: Department of Pathology, Università di Verona, Italy University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA Departamento de Anatomia Patologica, Instituto del Cancer de Solca, Cuenca, Ecuador |
2002 | Division of Epidemiology, Columbia University School of Public Health, 10032, New York, New York Dipartimento di Patologia − Sezione Anatomia Patologica, Università di Verona, Verona, Italy Molecular Virology Program, University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA 15213, USA. |
2001 | Division of Epidemiology, School of Public Health, Columbia University, New York, New York 10032 Department of Pathology Columbia University, New York, NY, USA Dipartimento di Patologia, Sezione di Anatomia Patologica, Università di Verona, Strada Le Grazie, Verona, Italy |
2000 | Department of Pathology‐Section of Anatomical Pathology, Università di Verona, Italy Division of Epidemiology, Columbia University, New York, New York |
Concept | World rank |
---|---|
enzyme pig kidney | #1 |
73500 bhutanese refugees | #1 |
ks seropositive | #1 |
loss endogenous yeast | #1 |
hvps39 2 | #1 |
cys111 plp | #1 |
lna kingsley | #1 |
investigation viral herpesvirus | #1 |
kshv causal association | #1 |
kaposi tissue donors | #1 |
molecular standpoint alterations | #1 |
africanendemic classic ks | #1 |
saah phair | #1 |
kshv years | #1 |
mcc advanced age | #1 |
335 420 nm | #1 |
ketone active | #1 |
ks accumulation | #1 |
endosomal protein effector | #1 |
dihydroxyphenylacetone | #1 |
plp optical activity | #1 |
seropositive kshv | #1 |
nm pig | #1 |
mcc bias carcinoma | #1 |
causal association kshv | #1 |
cmyc p16ink4 | #1 |
denmark mcc | #1 |
orf73 component | #1 |
human humans kaposi | #1 |
cancers mcc diagnosis | #1 |
virusinduced neoplasia | #1 |
surprisingly rich source | #1 |
emergence human herpesvirus | #1 |
methyldopa dopa decarboxylase | #1 |
ddc enzyme | #1 |
eastern tropical lowland | #1 |
missing vps3 | #1 |
deadend quinonoidal species | #1 |
1970s herpesvirus | #1 |
quinonoidal species | #1 |
mutant ddcs | #1 |
donorcell transmission | #1 |
missing vps3 subunit | #1 |
vps39like trap1 | #1 |
conversion internal aldimine | #1 |
noninfectious cofactors | #1 |
95 mcc diagnosis | #1 |
234kda lna | #1 |
complex vps3 | #1 |
update cgh | #1 |
Sign-in to see all concepts, it's free! | |
Prominent publications by Patrick S Moore
BACKGROUND: Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8, may be the infectious cause of KS. Its prevalence in the general population, on the basis of detection of the virus genome, is controversial. To investigate the seroprevalence, we measured antibodies to a recombinant capsid-related (lytic cycle) KSHV antigen and a latent antigen complex.
METHODS: We selected potentially immunoreactive capsid-related proteins of KSHV by expressing them as ...
Known for Capsid Protein | Antibodies Kshv | Viral Antigens | Herpesvirus Infection | Latent Antigen |
Detection of Herpesvirus-Like DNA Sequences in Kaposi's Sarcoma in Patients with and Those without HIV Infection
[ PUBLICATION ]
BACKGROUND: Herpesvirus-like DNA sequences have recently been found in lesions from patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS). It is not known whether these sequences are also present in classic Kaposi's sarcoma or in the Kaposi's sarcoma that occurs in homosexual men who are seronegative for the human immunodeficiency virus (HIV).
METHODS: We analyzed DNA in tissue samples from patients with AIDS-associated Kaposi's sarcoma, patients with classic ...
Known for Dna Sequence | Patients Kaposis Sarcoma | Hiv Infection | Aids Kaposi |
Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas
[ PUBLICATION ]
BACKGROUND: DNA fragments that appeared to belong to an unidentified human herpesvirus were recently found in more than 90 percent of Kaposi's sarcoma lesions associated with the acquired immunodeficiency syndrome (AIDS). These fragments were also found in 6 of 39 tissue samples without Kaposi's sarcoma, including 3 malignant lymphomas, from patients with AIDS, but not in samples from patients without AIDS.
METHODS: We examined the DNA of 193 lymphomas from 42 patients with AIDS and 151 ...
Known for Dna Sequences | Patients Aids | Based Lymphomas | Kaposi Sequence Analysis | Viral Herpesviridae Herpesvirus |
Merkel cell carcinoma (MCC) is the eponym for primary cutaneous neuroendocrine carcinoma. Recently, a new polyoma virus has been identified that is clonally integrated in the genome of the majority of MCCs, with truncating mutations in the viral large T antigen gene. We examined the presence of Merkel cell polyomavirus (MCV) in a set of 17 frozen tumor samples by quantitative polymerase chain reaction; 15 of them (88%) were positive. Sections from corresponding archival material were ...
Known for Neuroendocrine Carcinomas | Merkel Cell Carcinoma | Combined Tumors | Cell Polyomavirus | Neoplasm Dna |
BACKGROUND: Merkel cell polyomavirus (MCV) was discovered by digital transcriptome subtraction as a monoclonal infection of Merkel cell carcinoma (MCC) tumors. Subsequent studies have repeatedly confirmed that MCV is the likely cause for most MCC. Polymerase chain reaction-based detection of the virus in other nonmelanoma skin cancers, however, has been inconsistent and controversial.
OBJECTIVE: We sought to directly assay for MCV infection in squamous cell carcinoma (SCC) or basal cell ...
Known for Merkel Cell Carcinoma | Cell Polyomavirus | Immunocompetent Patients | Viral Female Humans | Mcv Mcc |
Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors
[ PUBLICATION ]
Merkel cell polyomavirus (MCV) is a recently discovered human virus closely related to African green monkey lymphotropic polyomavirus. MCV DNA is integrated in approximately 80% of Merkel cell carcinomas (MCC), a neuroendocrine skin cancer linked to lymphoid malignancies such as chronic lymphocytic leukemia (CLL). To assess MCV infection and its association with human diseases, we developed a monoclonal antibody that specifically recognizes endogenous and transfected MCV large T (LT) ...
Known for Merkel Cell | Polyomavirus Infection | Antigen Expression | Mcc Mcv | Dna Viral |
Alterations of K- ras, p53, p16 and DPC4/Smad4 characterize pancreatic ductal cancer (PDC). Reports of inactivation of these latter two genes in pancreatic endocrine tumours (PET) suggest that common molecular pathways are involved in the tumorigenesis of pancreatic exocrine and endocrine epithelia. We characterized 112 primary pancreatic tumours for alterations in p16 and DPC4 and immunohistochemical expression of DPC4. The cases included 34 PDC, 10 intraductal papillary-mucinous ...
Known for Acinar Cell Carcinoma | Pancreatic Tumours | Molecular Pathways | Ductal Cancer | Immunohistochemistry Loss |
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
[ PUBLICATION ]
BACKGROUND: Common genetic variants in immune and inflammatory response genes can affect the risk of developing non-Hodgkin lymphoma. We aimed to test this hypothesis using previously unpublished data from eight European, Canadian, and US case-control studies of the International Lymphoma Epidemiology Consortium (InterLymph).
METHODS: We selected 12 single-nucleotide polymorphisms for analysis, on the basis of previous functional or association data, in nine genes that have important ...
Known for Interlymph Consortium | Hodgkin Lymphoma | Tnf Il10 | Genetic Variation | Genotype Data |
BACKGROUND: If Kaposi's sarcoma-associated herpesvirus (KSHV) is the cause of Kaposi's sarcoma, serologic evidence of infection should be present in patients before the disease develops.
METHODS: Using an immunoblot assay for two latent nuclear antigens of KSHV, we tested serum samples from homosexual male patients with the acquired immunodeficiency syndrome (AIDS) with and without Kaposi's sarcoma (HIV-infected men with hemophilia), HIV-seronegative blood donors, and HIV-seronegative ...
Known for Nuclear Antigens | Kaposis Sarcoma | Kaposi Sensitivity | Infection Kshv | Seroconversion Antibodies |
Kaposi's Sarcoma-Associated Herpesvirus LANA2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p53
[ PUBLICATION ]
Kaposi's sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8, is associated with three proliferative diseases ranging from viral cytokine-induced hyperplasia to monoclonal neoplasia: multicentric Castleman's disease (CD), Kaposi's sarcoma (KS), and primary effusion lymphoma (PEL). Here we report a new latency-associated 1,704-bp KSHV spliced gene belonging to a cluster of KSHV sequences having homology to the interferon regulatory factor (IRF) family of transcription factors. ...
Known for Viral Protein | Herpesvirus Lana2 | Pel Kshv | Transcription Factors | Ks Lesions |
Merkel cell polyomavirus (MCV) is a newly-discovered human tumor virus found in approximately 80% of Merkel cell carcinoma (MCC). The rate of MCV infection among persons without MCC is unknown. We developed a MCV virus-like particle (VLP) enzyme-linked immunoassay (EIA) that does not cross-react with human BK or murine polyomaviruses. Peptide mapping of the MCV VP1 gene and immunoblotting with denatured MCV VLP are less sensitive than the MCV EIA in detecting MCV antibodies suggesting ...
Known for Human Merkel | Polyomavirus Infection | Mcc Patients | Mcv Antibodies | Aged 80 |
Extensive terminal and asymmetric processing of small RNAs from rRNAs, snoRNAs, snRNAs, and tRNAs
[ PUBLICATION ]
Deep sequencing studies frequently identify small RNA fragments of abundant RNAs. These fragments are thought to represent degradation products of their precursors. Using sequencing, computational analysis, and sensitive northern blot assays, we show that constitutively expressed non-coding RNAs such as tRNAs, snoRNAs, rRNAs and snRNAs preferentially produce small 5' and 3' end fragments. Similar to that of microRNA processing, these terminal fragments are generated in an asymmetric ...
Known for Small Rna | 5 Trfs | Dicer Processing | Human Cells | Degradation Products |
Dopa decarboxylase (DDC) catalyzes the cleavage of alpha-methylDopa into 3,4-dihydroxyphenylacetone and ammonia, via the intermediate alpha-methyldopamine, which does not accumulate during catalysis. The ketone has been identified by high-performance liquid chromatography and mass spectroscopic analysis, and ammonia by means of glutamate dehydrogenase. Molecular oxygen is consumed during the reaction in a 1:2 molar ratio with respect to the products. The kcat and Km of this reaction were ...
Known for Dopa Decarboxylase | Active Site | Reaction Ddc | Molecular Oxygen | Anaerobic Conditions |
The T Antigen Locus of Merkel Cell Polyomavirus Downregulates Human Toll-Like Receptor 9 Expression
[ PUBLICATION ]
Establishment of a chronic infection is a key event in virus-mediated carcinogenesis. Several cancer-associated, double-stranded DNA (dsDNA) viruses act via their oncoproteins to downregulate Toll-like receptor 9 (TLR9), a key receptor in the host innate immune response that senses viral or bacterial dsDNA. A novel oncogenic virus, Merkel cell polyomavirus (MCPyV), has been recently identified that causes up to 80% of Merkel cell carcinomas (MCCs). However, it is not yet known whether ...
Known for Merkel Cell | 9 Expression | Tumor Carcinoma | Polyomavirus Mcpyv | Oncogenic Virus |
Merkel cell carcinoma (MCC) is an aggressive skin cancer with a high mortality rate. The majority of MCC (70-80%) harbor clonally integrated Merkel cell polyomavirus (MCV) in the tumor genome and express viral T antigen oncoproteins. The characterization of an early passage MCV-positive MCC cell line MS-1 is described, and its cellular, immunohistochemical, and virological features to MCV-negative (UISO, MCC13, and MCC26) and MCV-positive cell lines (MKL-1 and MKL-2) were compared. The ...
Known for Merkel Cell | Tumor Carcinoma | Animals Antigens Viral | Polyomavirus Mcv | Positive Mcc |